everytraceeverytraceeverytraceeverytrace
all names

MSD organisation

Named in 4 reports across 1 story - 19 Aug – 23 Aug
19 Aug 202623 Aug 2026

The record - coverage naming MSD that changed after publication

2 edits2 entries
  1. ABC (Spain)seen 24 Aug, 16:25headline rewrittenthe story

    Lo que aún no sabemos de la vacuna que quiere revolucionar el tratamiento del cáncer contra el melanomaLas claves de la vacuna contra el melanoma

  2. El Mundo (Spain)seen 19 Aug, 21:52description editedthe story

The web around MSD

Closest companions, sized by how often they share a report with MSD. Lines between the outer names are their own relationships - names that appear together even without MSD.

Merck and Moderna share 2 reportsKTVU and Moderna share 1 reportEstados Unidos and Merck share 1 reportCNBC and Merck share 1 reportCNBC and Moderna share 1 reportCongreso de la Sociedad Europea de Oncología Médica and Merck share 1 reportKTVU and Merck share 1 reportArs Technica and Merck share 1 reportArs Technica and KTVU share 1 reportCanada and Moderna share 1 reportCongreso de la Sociedad Europea de Oncología Médica and Estados Unidos share 1 reportCongreso de la Sociedad Europea de Oncología Médica and ESMO share 1 reportCNBC and KTVU share 1 reportArs Technica and CNBC share 1 reportESMO and Merck share 1 reportESMO and Estados Unidos share 1 reportCanada and Merck share 1 reportArs Technica and Moderna share 1 reportARNm and Moderna share 1 reportMSDMerckMerck - 3 shared reports (organization)ModernaModerna - 3 shared reports (organization)ARNmARNm - 1 shared report (organization)Ars TechnicaArs Technica - 1 shared report (organization)CanadaCanada - 1 shared report (place)CNBCCNBC - 1 shared report (organization)Congreso de…Congreso de la Sociedad Europea de Oncología Médica - 1 shared report (organization)ESMOESMO - 1 shared report (organization)Estados Uni…Estados Unidos - 1 shared report (place)KTVUKTVU - 1 shared report (place)

The stories

Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma

43 outlets4 reports name MSD19 Aug – 27 Aug

Places in the same coverage

Canada1Estados Unidos1KTVU1Madrid1

Organisations in the same coverage

Merck3Moderna3ARNm1Ars Technica1CNBC1Congreso de la Sociedad Europea de Oncología Médica1ESMO1

Who keeps naming them

El Mundo (Spain)1Google News - Top Stories1MercoPress (South America)1ABC (Spain)1

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.